Medical Affairs Manager Surgery, Italy

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Fueled by innovation at the intersection of biology and technology, we’re developing the next generation of smarter, less invasive, more personalized treatments.

Your unique talents will help patients on their journey to wellness. Learn more at https://www.jnj.com/medtech

• →In alignment with senior leadership, implement BU medical strategy through local field tactics and ensure successful execution in collaboration with internal and external stakeholders. 
• →Serve as J&J local primary resource for medical and scientific information to HCPs, HCOs and other external stakeholders regarding BU therapeutic areas with a specific focus on Wound closure and Healing & Biosurgery 

• →Establish and nurture optimal peer-to-peer medical and scientific relationships with local/national HCPs and KOLs. Meet regularly with HCPs to assess their scientific needs, and identify ways to improve and facilitate access to our portfolio 

• →Develop strategic partnerships with both scientific stakeholders (HCPs, KOLs, HCOs, academic societies, faculties) and other stakeholders.

• →Conceive and lead advisory boards and expert meetings when needed. 

• →Support the identification and development of KOLs across BU/Surgery therapeutic areas as needed. 

• →Provide strong medical support, via evidence-based exchanges and peer-to-peer advocacy, for optimal launch and development of BU new products and solutions. 

• →Support J&J-sponsored evidence generation projects

• →Support external evidence generation projects in close collaboration with global/regional Scientific Affairs (Medical, Clinical, HEMA).

• →Support the development of local clinical research and educational projects. 

• →Provide HCPs with impartial scientific information and published evidence which accurately reflect risk benefit balance and support the appropriate use of BU products and services. 

• →Review and approve medical materials to ensure scientific accuracy and regulatory compliance.  
• →Support local teams in the management of individual HCP issues, e.g. helping them understand clinical research constraints, J&J processes and compliance requirements. 

• →Bring to J&J key insights from HCPs and external research environment.
• →Support Professional Education teams to implement higher-value educational partnerships. 

• →Support General Management to impartially assess & manage charitable contribution requests. 

• →Support EMEA Medical Safety & Quality teams to respond appropriately to unsolicited requests for information (MIR) from HCPs and with safety investigations in French. Assist Medical Safety & Quality team by reaching out to HCPs when additional information is needed. 
• →Continuous update on latest scientific and clinical advances in BU therapeutic areas and related topics.

• →Hence identify evolving trends in healthcare innovation, therapeutic strategy, patient pathway, unmet needs and evidence in BU therapeutic areas.